Anti-IL-20R2 antibody (ab124332)
- Datasheet
- References (2)
- Protocols
Overview
-
Product name
Anti-IL-20R2 antibody
See all IL-20R2 primary antibodies -
Description
Rabbit polyclonal to IL-20R2 -
Host species
Rabbit -
Tested applications
Suitable for: IHC-Pmore details -
Species reactivity
Reacts with: Human
Predicted to work with: Mouse, Rat -
Immunogen
Recombinant fragment corresponding to Human IL-20R2 aa 30-231.
-
Positive control
- Human fetal testis tissue.
-
General notes
Protein previously labeled as IL20RB.
Properties
-
Form
Lyophilised:Reconstitute in 200µl sterile H2O. -
Storage instructions
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles. -
Storage buffer
pH: 7.20
Preservative: 0.02% Sodium azide
Constituents: 98% PBS, 1% BSA -
Concentration information loading...
-
Purity
Immunogen affinity purified -
Clonality
Polyclonal -
Isotype
IgG -
Research areas
Associated products
-
Compatible Secondaries
-
Isotype control
-
Recombinant Protein
Applications
Our Abpromise guarantee covers the use of ab124332 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Application | Abreviews | Notes |
---|---|---|
IHC-P | 1/100 - 1/500. |
Target
-
Function
The IL20RA/IL20RB dimer is a receptor for IL19, IL20 and IL24. The IL22RA1/IL20RB dimer is a receptor for IL20 and IL24. -
Tissue specificity
Widely expressed with highest levels in skin and testis. Highly expressed in psoriatic skin. -
Sequence similarities
Belongs to the type II cytokine receptor family.
Contains 2 fibronectin type-III domains. -
Cellular localization
Membrane. - Information by UniProt
-
Database links
- Entrez Gene: 53833 Human
- Entrez Gene: 213208 Mouse
- Entrez Gene: 501043 Rat
- Omim: 605621 Human
- SwissProt: Q6UXL0 Human
- Unigene: 61232 Human
-
Alternative names
- DIRS1 antibody
- Fibronectin type III domain containing 6 antibody
- FNDC6 antibody
see all
Images
Protocols
References
This product has been referenced in:
- An W et al. Exogenous IL-19 attenuates acute ischaemic injury and improves survival in male mice with myocardial infarction. Br J Pharmacol N/A:N/A (2018). Read more (PubMed: 30460984) »
- Steinert A et al. The Stimulation of Macrophages with TLR Ligands Supports Increased IL-19 Expression in Inflammatory Bowel Disease Patients and in Colitis Models. J Immunol 199:2570-2584 (2017). Read more (PubMed: 28864472) »